Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Psychopharmacology (Berl). 2018 Jan 29;235(4):1179–1189. doi: 10.1007/s00213-018-4834-7

Table 1.

Number of mice from arrival at the Scripps Research Institute through completion of progressive ratio testing including percent meeting acquisition criteria. Attrition after acquisition was mainly due to loss of patency

Arrived Survived Surgery Survived Recovery Completed Acquisition Failed to Meet Criteria Pct Meeting Criteria Extinction Reacquisition Dose Response Progressive Ratio
Low Responders BTBR T+ tf/J 20 19 17 14 5 64 5 4 3 3
FVB/NJ 40 35 34 24 18 25 6 1 1 0
LG/J 28 24 17 17 4 76 13 8 7 4
LP/J 32 26 24 22 12 45 9 4 4 3
High Responders C57BL/6J 58 49 44 36 8 78 24 12 10 5
C57BR/cdJ 20 13 13 13 3 77 10 4 4 2
I/LnJ 19 16 15 15 0 100 14 10 10 10
P/J 19 18 17 16 6 63 8 4 2 1